ANI Pharmaceuticals Inc’s recently made public that its Director Leonard Matthew J unloaded Company’s shares for reported $0.61 million on Aug 18 ’25. In the deal valued at $88.17 per share,6,937 shares were sold. As a result of this transaction, Leonard Matthew J now holds 9,392 shares worth roughly $0.84 million.
Then, Walsh Patrick D sold 9,000 shares, generating $801,450 in total proceeds. Upon selling the shares at $89.05, the Director now owns 70,048 shares.
Before that, Shanmugam Muthusamy sold 52,990 shares. ANI Pharmaceuticals Inc shares valued at $4,618,078 were divested by the HEAD OF R&D, COO-NOVITIUM OPS at a price of $87.15 per share. As a result of the transaction, Shanmugam Muthusamy now holds 531,920 shares, worth roughly $47.72 million.
H.C. Wainwright initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on July 10, 2025; the price target was $84. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering ANIP with “an Overweight” recommendation on March 12, 2025. Leerink Partners started covering the stock on December 11, 2024. It rated ANIP as “an Outperform”.
Price Performance Review of ANIP
On Monday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 2.56% to $89.71. Over the last five days, the stock has gained 5.69%. ANI Pharmaceuticals Inc shares have risen nearly 51.54% since the year began. Nevertheless, the stocks have risen 62.28% over the past one year. While a 52-week high of $90.23 was reached on 08/18/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 87.74, which if violated will result in even more drops to 85.77. On the upside, there is a resistance level at 91.25. A further resistance level may holdings at 92.80.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-07-31, growing by 0.2 million shares to a total of 2.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 2.0 million shares. There was a rise of 9.26%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $68 price target.
